Vioquest Pharmaceutl (VOQP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 650 | 3,210 | N/A | 30 | 70 |
| Receivables | 50 | 0 | N/A | 30 | 50 |
| Inventories | 70 | 0 | N/A | 160 | 180 |
| Other current assets | 60 | 70 | 0 | 50 | 20 |
| TOTAL | $830 | $3,280 | $N/A | $270 | $320 |
| Non-Current Assets | |||||
| PPE Net | 250 | 0 | N/A | 20 | 10 |
| Other Non-Current Assets | 490 | 0 | 0 | 9 | 7 |
| TOTAL | $740 | $N/A | $N/A | $29 | $17 |
| Total Assets | $1,580 | $3,280 | $N/A | $310 | $340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 270 | 120 | 0 | 30 | 40 |
| Accrued Expenses | 220 | 5 | N/A | 50 | 50 |
| Other current liabilities | 220 | 0 | N/A | 0 | 0 |
| TOTAL | $720 | $130 | $N/A | $140 | $150 |
| Non-Current Liabilities | |||||
| TOTAL | $40 | $N/A | $N/A | $10 | $N/A |
| Total Liabilities | $760 | $130 | $N/A | $150 | $150 |
| Shareholders' Equity | |||||
| Common Shares | 130 | 40 | N/A | 4,600 | 4,470 |
| Retained earnings | -3,410 | -5,100 | N/A | -4,850 | -4,680 |
| Other shareholders' equity | -760 | 0 | 0 | 400 | 390 |
| TOTAL | $820 | $3,150 | $N/A | $150 | $180 |
| Total Liabilities And Equity | $1,580 | $3,280 | $0 | $300 | $330 |